SCHEMBL8243192

SCHEMBL8243192

CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNC(COCCC(C)(C)C)CC(C)N

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.47
CTSD P07339 19/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1521789 0.76 CTSD (0.58) BACE1CTSD
SCHEMBL1522064 0.75 BACE1 (0.57) BACE1CTSD
SCHEMBL1521787 0.75 BACE1 (0.53) BACE1CTSD
SCHEMBL1522006 0.74 CTSD (0.52) BACE1CTSD
SCHEMBL1521706 0.74 BACE1 (0.54) BACE1CTSD
SCHEMBL13907324 0.70 BACE1 (0.60) BACE1CTSD
SCHEMBL1521772 0.70 BACE1 (0.60) BACE1CTSD
SCHEMBL1521718 0.69 BACE1 (0.59) BACE1CTSD
SCHEMBL8241357 0.69 BACE1 (0.55) BACE1CTSD
SCHEMBL1521809 0.69 BACE1 (0.58) BACE1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007047305-A1 METHODS OF TREATING AMYLOIDOSIS USING CYCLOPROPYL DERIVATIVE ASPARTYL PROTEASE INHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2007-04-26 WO disclosed